The United States Department of Justice, the Department of Health and Human Services Office of Inspector General, and 50 state Medicaid Fraud Control Units announced the results of the 2026 National Health Care Fraud Takedown on June 24 — the broadest multi-district healthcare fraud enforcement action of the year.
According to the HHS-OIG's announcement, the takedown charged 455 defendants, including 90 licensed medical professionals across 56 federal districts in 45 U.S. states and territories for participation in healthcare fraud and opioid abuse schemes involving more than $6.5 billion in alleged false claims and significant patient harm, including death.
Why This Matters
Health care fraud is not a victimless category of white-collar crime. When physicians and other licensed medical professionals submit false claims, the consequences include: real patients receiving unnecessary procedures; real patients not receiving care that is medically indicated because it was substituted with a fraudulent alternative; federal program resources being depleted; and in the most serious cases, patient deaths.
The involvement of 90 licensed medical professionals — physicians, nurses, pharmacists, and other credentialed providers — in a single coordinated enforcement action is significant not only for its scale but for the signal it sends about the scope of professional accountability the HHS-OIG and DOJ are prepared to pursue.
CMS suspended billing privileges for 1,403 providers and revoked them for 1,079 more as part of the 2026 action — expanding the protective effect well beyond the 455 criminal defendants.
What the Takedown Covered
Based on HHS-OIG's enforcement data and DOJ case summaries, the 2026 takedown covered several major categories:
Telehealth billing fraud ($1.17 billion). Forty-nine defendants were charged in connection with telehealth and genetic testing fraud — including schemes where telemedicine platforms paid physicians to sign orders for medically unnecessary tests, equipment, and medications for patients they had never examined. As covered in MedicalDaily's prior reporting on the Aptihealth settlement, some telehealth mental health companies billed Medicare and Medicaid for appointments that never occurred.
Skin substitute wound care fraud ($10 billion in the broader billing context). Cases involving fraudulent billing for skin graft allografts — covered in MedicalDaily's prior reporting on the Medicare wound care billing scandal — continued to generate criminal charges in 2026, with the CMS payment reform that took effect January 1, 2026 generating a new wave of enforcement actions against prior-period fraud.
Opioid-related schemes. A specific focus of the 2026 takedown was healthcare fraud tied to opioid distribution — including physicians prescribing controlled substances without legitimate medical examination, pharmacies filling prescriptions that lacked clinical justification, and schemes that directly contributed to patient harm and deaths.
Durable medical equipment fraud. Cases involving fraudulent billing for wheelchairs, orthotic braces, and home health equipment — sometimes ordered for patients who needed no such equipment — appeared in multiple federal districts.
Community mental health fraud. The Southern District of Florida included charges against 12 defendants in connection with more than $4 billion in allegedly fraudulent claims for community mental health services, illustrating the scale at which certain provider categories have been able to exploit billing vulnerabilities.
The Physician Defendant Count
Ninety of the 455 defendants are licensed medical professionals — a category that includes physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other credentialed providers. This figure matters because:
- Physician participation in fraud often amplifies its scale — physicians' prescription authority and clinical certification create billing pathways that non-physician co-conspirators cannot access independently.
- License suspension and criminal conviction have long-term protective effects beyond the individual case — they remove the professional from future fraudulent billing schemes.
- The physician defendant count reflects the HHS-OIG's and DOJ's stated priority of pursuing the highest-level enablers of healthcare fraud schemes rather than exclusively targeting billing staff and corporate defendants.
What Doctors and Experts Say
David Tawes, Regional Inspector General with the HHS-OIG's Office of Evaluation and Inspections, noted in comments to Medical Economics earlier in 2026 that the increase in telemedicine fraud has emerged as one of the fastest-growing categories the agency tracks — specifically because the removal of geographic and in-person barriers that makes telehealth valuable to legitimate patients also removes friction that previously deterred some fraud schemes.
The A.I.-powered Fraud Defense Operations Center deployed by CMS has significantly accelerated the identification of billing anomalies that previously took years to surface through manual claims review. Cases where a medical group practice submitted millions of dollars in claims for services to patients without any documented wounds are now being flagged in real time rather than discovered through years-later audits.
What the Evidence Shows — and What It Does Not
The 2026 takedown reflects alleged fraud and charges — defendants are presumed innocent until proven guilty. The dollar figures ($6.5 billion in alleged false claims) represent what prosecutors contend was billed, not necessarily what was paid, and the actual losses to federal and state programs are typically calculated separately in individual case proceedings.
The 455-defendant count, 90 licensed professional defendants, and 56-district geographic scope are all confirmable facts from official DOJ and HHS-OIG announcements.
Who Is Most Affected?
- Medicare and Medicaid beneficiaries who were subjected to unnecessary procedures, were denied appropriate care, or were otherwise harmed by fraudulent scheme participants
- Taxpayers and program beneficiaries whose premiums and program costs are inflated by the fraud
- Legitimate healthcare providers who compete with fraudulent billers for the same patient populations
- Patients who were prescribed opioids through schemes designed to generate billing rather than provide clinical care
What You Can Do Now
- Review your Medicare Explanation of Benefits for any claims you do not recognize. Report unrecognized claims to 1-800-MEDICARE (1-800-633-4227).
- Report suspected healthcare fraud to the HHS OIG Hotline at 1-800-HHS-TIPS (1-800-447-8477).
- If you believe a telehealth provider billed your insurance for services that did not occur, contact your insurer directly and request a refund of any copay you paid.
What Happens Next
The 2026 National Health Care Fraud Takedown will generate individual prosecutions, plea agreements, and trials throughout the rest of 2026 and into 2027. CMS's expanded fraud detection AI program is expected to accelerate the identification of new cases. MedicalDaily will continue reporting on significant individual case outcomes and on any changes to billing oversight regulations that result from the takedown findings.
The Bottom Line
The 2026 National Health Care Fraud Takedown charged 455 defendants — including 90 licensed medical professionals — for participating in schemes that generated $6.5 billion in false claims and caused significant patient harm, including deaths. The action spans 56 federal districts across 45 states, making it the broadest multi-district healthcare fraud enforcement action of the year. Medicare and Medicaid beneficiaries should check their Explanation of Benefits for unrecognized claims and report any suspected fraud to the OIG hotline.
